Peace, i exoect a 100 million deal might look like
1/2 million up front; 1-2 million after in-vitro; 2-5 million after animal testing, 5-10 million after phase 1; 10-20 phase 11; 20-30 million Phase 111; the balance on registration and approval with FDA.
Then maybe royalties starting at 7 % and rsing with sales benchmarks.
Just a rough idea of how it plays out. As for Eli Lilly they are like the rest running out of pipeline, prefer more certainty but without the price tag certainty brings.
All about balance. The more irons they have in early stage the more chance of a Blocbuster. It seems BIOLOGICS is the place to be and the ASX has them in spades.
PoS
Peace, i exoect a 100 million deal might look like1/2 million up...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.000(0.00%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.44 | $1.34 | $1.022M | 752.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 692 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5666 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |